147 related articles for article (PubMed ID: 32964250)
1. Enhanced patterns on intraoperative contrast-enhanced ultrasonography predict outcomes after curative liver resection in patients with hepatocellular carcinoma.
Nakamura I; Hatano E; Tada M; Kawabata Y; Tamagawa S; Kurimoto A; Iwama H; Toriguchi K; Sueoka H; Iida K; Yoshida M; Nishimura T; Iijima H
Surg Today; 2021 May; 51(5):764-776. PubMed ID: 32964250
[TBL] [Abstract][Full Text] [Related]
2. IOUS and CE-IOUS during hepatic resection for patients with hepatocellular carcinoma in liver cirrhosis1.
Gong NM; Yin HH; Cai WH; Li QW; Wang JX; Gu CY; Wang YF; Wu J; Zhang YF
Clin Hemorheol Microcirc; 2019; 71(4):483-498. PubMed ID: 30248049
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
Wang Y; Liao J; Qi W; Xie L; Li Y
Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: clinical and biological significance.
Sato K; Tanaka S; Mitsunori Y; Mogushi K; Yasen M; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
Hepatology; 2013 Apr; 57(4):1436-47. PubMed ID: 23150500
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Contrast-enhanced Ultrasound for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection.
Xiachuan Q; Xiang Z; Xuebing L; Yan L
Ultrason Imaging; 2019 Jan; 41(1):49-58. PubMed ID: 30803409
[TBL] [Abstract][Full Text] [Related]
6. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative ultrasound for prediction of hepatocellular carcinoma biological behaviour: Prospective comparison with pathology.
Santambrogio R; Cigala C; Barabino M; Maggioni M; Scifo G; Bruno S; Bertolini E; Opocher E; Bulfamante G
Liver Int; 2018 Feb; 38(2):312-320. PubMed ID: 28732141
[TBL] [Abstract][Full Text] [Related]
8. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
9. Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
Eur Radiol; 2014 Sep; 24(9):2157-66. PubMed ID: 24952601
[TBL] [Abstract][Full Text] [Related]
10. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection.
Wakayama K; Kamiyama T; Yokoo H; Orimo T; Shimada S; Einama T; Kamachi H; Taketomi A
J Surg Oncol; 2017 Mar; 115(3):324-329. PubMed ID: 28192617
[TBL] [Abstract][Full Text] [Related]
11. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
[TBL] [Abstract][Full Text] [Related]
12. Nuclear PKM2 expression, an independent risk factor for ER after curative resection of hepatocellular carcinoma.
Fan F; Wu H; Liu Z; Hou X; Chen W; Wang A; Lu Y
Biomed Pharmacother; 2016 Dec; 84():1858-1864. PubMed ID: 27894667
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.
Gao Y; Zheng DY; Cui Z; Ma Y; Liu YZ; Zhang W
World J Gastroenterol; 2015 Sep; 21(36):10418-26. PubMed ID: 26420968
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
[TBL] [Abstract][Full Text] [Related]
16. Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection.
Cui J; Dong BW; Liang P; Yu XL; Yu DJ
World J Gastroenterol; 2004 May; 10(10):1533-6. PubMed ID: 15133868
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative ultrasound score to predict recurrent hepatocellular carcinoma after radical treatments.
Santambrogio R; Costa M; Strada D; Bertolini E; Zuin M; Barabino M; Opocher E
Ultrasound Med Biol; 2011 Jan; 37(1):7-15. PubMed ID: 21084155
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Contrast-Enhanced Ultrasonic Imaging Reflects Microvascularization in Hepatocellular Carcinoma and Prognosis after Resection.
Zou RH; Lin QG; Huang W; Li XL; Cao Y; Zhang J; Zhou JH; Li AH; Beretta L; Qian CN
Ultrasound Med Biol; 2015 Oct; 41(10):2621-30. PubMed ID: 26210785
[TBL] [Abstract][Full Text] [Related]
20. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
